miRNA expression and interaction with genes involved in susceptibility to pristane-induced arthritis


Butantan affiliation
External affiliation
Publication type
Article
Language
English
Access rights
Open access
Terms of use
CC BY
Appears in Collections:
Metrics
Abstract
Pristane-induced arthritis (PIA) in mice is an experimental model that resembles human rheumatoid arthritis, a chronic autoimmune disease that affects joints and is characterized by synovial inflammation and articular cartilage and bone destruction. AIRmax and AIRmin mouse lines differ in their susceptibility to PIA, and linkage analysis in this model mapped arthritis severity QTLs in chromosomes 5 and 8. miRNAs are a class of small RNA molecules that have been extensively studied in the development of arthritis. We analyzed miRNA and gene expression profiles in peritoneal cells of AIRmax and AIRmin lines, in order to evaluate the genetic architecture in this model. Susceptible AIRmax mice showed higher gene (2025 vs 1043) and miRNA (240 vs 59) modulation than resistant AIRmin mice at the onset of disease symptoms. miR-132-3p/212-3p, miR-106-5p, miR-27b-3p, and miR-25-3p were among the miRNAs with the highest expression in susceptible animals, showing a negative correlation with the expression of predicted target genes (Il10, Cd69, and Sp1r1). Our study showed that global gene and miRNA expression profiles in peritoneal cells of susceptible AIRmax and resistant AIRmin lines during pristane-induced arthritis are distinct, evidencing interesting targets for further validation.
Reference
Fernandes JG, Borrego A, Jensen JR, Cabrera WHK, Corrêa MA, Starobinas N, et al. miRNA expression and interaction with genes involved in susceptibility to pristane-induced arthritis. J Immunol Res. 2018 Dec;2018:1928405. doi:10.1155/2018/1928405.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/2647
URL
http://dx.doi.org/10.1155/2018/1928405
Issue Date
2018


Files in This Item:

10.115520181928405.pdf
Size: 7.36 MB
Format: Adobe PDF
View/Open
Show full item record

This item is licensed under a Creative Commons License Creative Commons